David Borenstein, M.D.

The appellant appealed the Ministry of Transportation's decision to downgrade his commercial Class B driver's licence to a Class G licence due to his medical history.

The appellant had a history of cardiovascular disease, including an aortic valve replacement and atrial fibrillation.

The Ministry relied on CCMTA and CMA guidelines, which state that commercial drivers cannot be receiving intermittent or outpatient treatment with inotropic drugs.

Although the appellant argued he only received such drugs in the hospital, the Tribunal found that his daily use of Amiodarone constituted ongoing inotropic drug treatment.

The Tribunal concluded the appellant did not meet the safety standards for a commercial licence and confirmed the Ministry's decision.

The Appellant appealed the Registrar of Motor Vehicles' decision to suspend his driver's licence for medical reasons, specifically related to bipolar disorder and alcohol dependence.

The Licence Appeal Tribunal found that the Appellant had been psychiatrically stable for over five years and had met the CCMTA medical standards for substance abuse remission, supported by favourable recommendations from an addictions specialist and his family physician.

The Tribunal concluded that the Appellant did not suffer from a condition or addiction likely to significantly interfere with his ability to drive safely, and set aside the Registrar's decision.